Clinical Outcomes of People Who Acquired HIV in Early Life
Public ClinicalTrials.gov record NCT01656564. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Outcomes in Persons With HIV Acquired Early in Life
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: \- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested in studying how HIV infection and the medicines used to treat it affect people who were infected early in life. They want to find out if there are any problems with how HIV-infected children grow and develop as adults, especially if they have developed heart problems. As part of this study, people with HIV will be compared with healthy volunteers. Objectives: \- To study the effect of HIV infection and treatment on people who acquired HIV infection in early life. Eligibility: * Individuals at least 18 years of age who acquired HIV infection in early life. * Healthy volunteers at least 18 years of age without HIV will serve as controls Design: * Participants will be screened with a physical exam and medical history. They will have regular study visits about once a year for up to 10 years to collect health information. * Blood and urine samples will be collected to look at kidney and liver function. * X-ray scans will be used to look at bone density and the amount of fat and muscle in the body. * Treatment will not be provided as part of this study.
Study identification
- NCT ID
- NCT01656564
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 177 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 26, 2012
- Primary completion
- Mar 7, 2023
- Completion
- Mar 7, 2023
- Last update posted
- Mar 8, 2023
2012 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01656564, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2023 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01656564 live on ClinicalTrials.gov.